PMID- 31902044
OWN - NLM
STAT- MEDLINE
DCOM- 20210402
LR  - 20210402
IS  - 1708-0428 (Electronic)
IS  - 0960-8923 (Linking)
VI  - 30
IP  - 3
DP  - 2020 Mar
TI  - Outcome and Adverse Events of Endoscopic Bariatric Stents for Management of 
      Leakage after Bariatric Surgery.
PG  - 982-991
LID - 10.1007/s11695-019-04373-7 [doi]
AB  - INTRODUCTION: Bariatric leakage (BL) is a serious complication with a variety in 
      available treatment options. Endoscopic stenting is preferred because of its 
      minimally invasive nature in morbidly obese patients. Various modifications have 
      been applied to stents since its use in palliation of malignant strictures. Few 
      studies have exclusively evaluated the efficacy of bariatric stents in management 
      BL. METHODS: A retrospective cohort study of patients with BL managed by 
      bariatric stents in the period between July 2014 and January 2019. The primary 
      outcome was the clinical success in healing of leakage and secondary outcomes 
      included adverse events (AEs), hospital stay and procedure-related mortality. 
      RESULTS: Forty-five patients were included in this study. Clinical success 
      occurred in 33 patients (73.3%). There was no stent-related mortality. The most 
      frequent stent-related complications were reflux (62.2%), intolerance (55.6%), 
      and migration (17.8%). Severe AEs occurred in 9 patients (20%). The overall 
      complications rate was higher in diabetic patients (P = 0.048). Intolerance was 
      significantly associated with shorter interval to management (P = 0.02). Stent 
      migration was higher in male patients (P = 0.019) and higher BMI (P = 0.024). 
      CONCLUSION: Endoscopic stenting is a double-edged weapon that must be handled 
      cautiously. It is a highly effective therapy, and early intervention is the main 
      determinant of its efficacy. But it is not a treatment without complications 
      (80%). The variant and high prevalence of complications mandates a strict 
      follow-up throughout the stenting duration.
FAU - Hamed, Hosam
AU  - Hamed H
AUID- ORCID: 0000-0003-2774-2947
AD  - Gastrointestinal Surgical Center, Mansoura University, Jehan street, Postal code, 
      Mansoura, Dakahleyya, 35516, Egypt. Hosam-eldin@hotmail.com.
FAU - Said, Mohammed
AU  - Said M
AD  - General Surgery Department, Mansoura University, Jehan street, Mansoura, 
      Dakahleyya, Egypt.
FAU - Elghadban, Hosam
AU  - Elghadban H
AD  - General Surgery Department, Mansoura University, Jehan street, Mansoura, 
      Dakahleyya, Egypt.
FAU - Elgeidie, Ahmed
AU  - Elgeidie A
AD  - Gastrointestinal Surgical Center, Mansoura University, Jehan street, Mansoura, 
      Dakahleyya, Egypt.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Obes Surg
JT  - Obesity surgery
JID - 9106714
SB  - IM
MH  - Adult
MH  - Anastomotic Leak/epidemiology/*surgery
MH  - Bariatric Surgery/*adverse effects
MH  - Cohort Studies
MH  - *Endoscopy, Gastrointestinal/adverse effects/instrumentation/statistics & 
      numerical data
MH  - Female
MH  - Humans
MH  - Length of Stay
MH  - Male
MH  - Obesity, Morbid/epidemiology/*surgery
MH  - Postoperative Complications/epidemiology/etiology/pathology/surgery
MH  - *Reoperation/adverse effects/methods/statistics & numerical data
MH  - Retrospective Studies
MH  - Severity of Illness Index
MH  - *Stents/adverse effects
MH  - Treatment Outcome
MH  - Young Adult
OTO - NOTNLM
OT  - Bariatric
OT  - Endotherapy
OT  - Leakage
OT  - Stenting
EDAT- 2020/01/07 06:00
MHDA- 2021/04/07 06:00
CRDT- 2020/01/06 06:00
PHST- 2020/01/07 06:00 [pubmed]
PHST- 2021/04/07 06:00 [medline]
PHST- 2020/01/06 06:00 [entrez]
AID - 10.1007/s11695-019-04373-7 [pii]
AID - 10.1007/s11695-019-04373-7 [doi]
PST - ppublish
SO  - Obes Surg. 2020 Mar;30(3):982-991. doi: 10.1007/s11695-019-04373-7.